Deaths may peak in April
Category: russellflanneryblog
Forbes Midas Lister Nisa Leung To Leave Venus Medtech Board
Leung, a partner at investment firm Qiming Development (HK) who leads its healthcare investments, will depart “due to other work commitments,” the statement said.
China Stocks Climb Again; Investors See More Benefits Than Risk In Covid Policy Shift
Risks include a spike in cases and deaths
Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties, Kevin Rudd Says
“If we get this one right on cancer, it’s going to add this whole new positive dynamic to the overall framework of the U.S.-China relationship, the Asia Society CEO told an online symposium.
Huaxia Eye Hospital IPO Mints China’s Latest Billionaire
China is home to the world’s second-largest number of billionaires
MeHow Shenzhen Listing Mints New China Medical Device Billionaire
China is home to the world’s second-largest number of billionaires after the United States
Two Areas Where The U.S. And China Can Still Work Together
The fight against cancer and push to a carbon neutral future offer promise, experts at an Asia Society conference in New York said this week
Raffles Medical Group Sees China On The Mend From Covid As Its Expansion Continues
Raffles Medical Group from Singapore plans to increase the number of cities it serves in China from the current eight to 20 in the next three to five years.
U.S. Cancer Moonshot Needs Stronger Int’l Effort To Make Substantial Progress – Kevin Rudd
“International trials have been key to accelerating the breakthroughs that we’ve seen so far,” Rudd told the Forbes China Healthcare Summit
From Patient To Policy Insider: Greg Simon’s Cancer Rx Includes A Better White House Rallying Call
The “Cancer Moonshot” should be renamed “Human Moonshot” as part of a true global effort, Simon tells Forbes China Healthcare Forum
